Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 211 AL 225

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

Huang Y, Chang Y, Liu L, Wang J.

Molecules. 2021 Jul 15;26(14):4301. doi: 10.3390/molecules26144301.

Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer's disease

Ding XW, Robinson M, Li R, Aldhowayan H, Geetha T, Babu JR.

Pharmacol Res. 2021 Sep;171:105783. doi: 10.1016/j.phrs.2021.105783. Epub 2021 Jul 22.

Chemical update on the potential for serotonin 5-HT(6) and 5-HT(7) receptor agents in the treatment of Alzheimer's disease

Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J.

Bioorg Med Chem Lett. 2021 Oct 1;49:128275. doi: 10.1016/j.bmcl.2021.128275. Epub 2021 Jul 23.

Alzheimer's disease: the controversial approval of Aducanumab

Tagliavini F, Tiraboschi P, Federico A.

Neurol Sci. 2021 Aug;42(8):3069-3070. doi: 10.1007/s10072-021-05497-4. Epub 2021 Jul 29.

Metal Complexation Mechanisms of Polyphenols Associated to Alzheimer's Disease

Kola A, Dudek D, Valensin D.

Curr Med Chem. 2021;28(35):7278-7294. doi: 10.2174/0929867328666210729120242.

Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer's disease

Handa M, Tiwari S, Yadav AK, Almalki WH, Alghamdi S, Alharbi KS, Shukla R, Beg S.

Drug Discov Today. 2021 Dec;26(12):2881-2888. doi: 10.1016/j.drudis.2021.07.020. Epub 2021 Jul 29.

In vivo functions of p75(NTR): challenges and opportunities for an emerging therapeutic target

Malik SC, Sozmen EG, Baeza-Raja B, Le Moan N, Akassoglou K, Schachtrup C.

Trends Pharmacol Sci. 2021 Sep;42(9):772-788. doi: 10.1016/j.tips.2021.06.006. Epub 2021 Jul 29.

Effect of involuntary chronic physical exercise on beta-amyloid protein in experimental models of Alzheimer's disease: Systematic review and meta-analysis

Vasconcelos-Filho FSL, da Rocha Oliveira LC, de Freitas TBC, de Pontes PADS, Rocha-E-Silva RCD, Godinho WDN, Chaves EMC, da Silva CGL, Soares PM, Ceccatto VM.

Exp Gerontol. 2021 Oct 1;153:111502. doi: 10.1016/j.exger.2021.111502. Epub 2021 Jul 31.

Pilot evaluation of a consumer wearable device to assess sleep in a clinical polysomnography trial of suvorexant for treating insomnia in patients with Alzheimer's disease

Svetnik V, Wang TC, Ceesay P, Snyder E, Ceren O, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D, Herring WJ.

J Sleep Res. 2021 Dec;30(6):e13328. doi: 10.1111/jsr.13328. Epub 2021 Aug 2.

Use of Hormone Therapy in Postmenopausal Women with Alzheimer's Disease: A Systematic Review

Cardinali CAEF, Martins YA, Torrão AS.

Drugs Aging. 2021 Sep;38(9):769-791. doi: 10.1007/s40266-021-00878-y. Epub 2021 Aug 3.

Melatonin and Sleep Disturbances in Alzheimer's Disease

Prodhan AHMSU, Cavestro C, Kamal MA, Islam MA.

CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.

Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols

Zhang M, Hu G, Shao N, Qin Y, Chen Q, Wang Y, Zhou P, Cai B.

Inflammopharmacology. 2021 Oct;29(5):1317-1329. doi: 10.1007/s10787-021-00861-4. Epub 2021 Aug 4.

Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease

Ji W, Gong B, Jin H, Chen X, Li P, Cheng W, Zhao Y, He B, Zhuang J, Gao J, Yin Y.

Mini Rev Med Chem. 2021;21(19):3062-3072. doi: 10.2174/1389557521666210805110920.

Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S.

Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6.

Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions

Nascimento-Dos-Santos G, de-Souza-Ferreira E, Linden R, Galina A, Petrs-Silva H.

Cells. 2021 Jul 20;10(7):1827. doi: 10.3390/cells10071827.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias